Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:50:17 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



V:XRTX - XORTX Therapeutics Inc. - https://www.xortx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
XRTX - V  0.21.25·1.350.31.25-0.04-3.12.0251.30  1.30  1.253.88  1.0815:59:01Jun 2615 min RT 2¢
TSX-V - V0.21.25·1.350.31.28-0.01-0.81.0121.28  1.28  1.283.88  1.0815:44:0115 min
Pure - P 1.25-0.04-3.11.0131.30  1.30  1.2515:59:0115 min

Recent Trades - All 5 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:01P1.25-0.045001 Anonymous80 National BankK
15:44:01V1.28-0.015001 Anonymous124 QuestradeK
15:10:58V1.28-0.0150079 CIBC124 QuestradeKL
11:51:27P1.300.0150080 National Bank1 AnonymousK
09:40:46P1.26-0.031180 National Bank83 Research CapE
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-06-26 16:16C:XRTX1.11News ReleaseXORTX arranges $925,000 (U.S.) private placement
2025-05-20 01:52C:XRTX1.44News ReleaseXORTX arranges $3-million (U.S.) private placement
2025-05-16 00:43C:XRTX1.31SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-16 00:43C:XRTX1.31SEDAR Interim MD & ASEDAR Interim MD & A
2025-04-30 15:27C:XRTX1.47News ReleaseXORTX Therapeutics clarifies steps for XRx-026 NDA
2025-04-28 16:14C:XRTX1.53News ReleaseXORTX receives patent in Europe
2025-04-17 20:38C:XRTX1.29News ReleaseXORTX has 180 days to remedy Nasdaq listing deficiency
2025-03-31 07:35C:XRTX1.41SEDAR Annual Information FormSEDAR Annual Information Form
2025-03-26 00:56C:XRTX1.38SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-03-26 00:56C:XRTX1.38SEDAR MD & ASEDAR MD & A
2025-03-19 14:11C:XRTX1.35News ReleaseXORTX to provide Type B package to FDA for XRx-026
2025-02-24 17:29C:XRTX1.19News ReleaseXORTX submits XRx-026 Type C meeting request with FDA
2025-01-29 07:00C:XRTX1.38News ReleaseXORTX to Present at Microcap Conference
2025-01-17 17:33C:XRTX1.46News ReleaseXORTX Therapeutics switches auditors to Davidson Co.
2025-01-06 17:25C:XRTX1.92News ReleaseXORTX begins XRx-026 late-stage gout program
2024-12-19 14:57C:XRTX1.62News ReleaseXORTX Therapeutics appoints Bumby as CFO
2024-12-12 09:17C:XRTX1.70News ReleaseXORTX Announces Presentation at the Rare and Genetic Disease Summit
2024-11-18 20:40C:XRTX1.74Private PlacementXORTX Therapeutics private placement
2024-11-14 20:30C:XRTX1.95SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-14 20:30C:XRTX1.95SEDAR Interim MD & ASEDAR Interim MD & A